Young age, female sex, and no comorbidities are risk factors for adverse reactions after the third dose of bnt162b2 covid-19 vaccine against sars-cov-2: a prospective cohort study in japan

HIGHLIGHTS

• who: Ryuta Urakawa et al. from the Study in Japan Department of Pharmacy, Osaka University Dental Hospital, Yamada-oka, Suita, Osaka, Japan have published the research: Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan, in the Journal: Vaccines 2022, 10, 1357. of 29/07/2022
• what: Background: This study compared the adverse events (AEs) of the second and third doses of BNT162b2 as well as investigated the impact of vaccine recipients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.